← Open Payments lookup

KARIN SHEARS: Open Payments

NPI 1922415801 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$937 in 27 payments from 8 companies in 2025. Trend: 2023 $269 · 2024 $333 · 2025 $937

Food & beverage: $937
CompanyPaymentsAmount
Madrigal Pharmaceuticals6$465
ABBVIE INC.5$113
Mallinckrodt Hospital Products Inc.4$91
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
Ipsen Biopharmaceuticals, Inc3$83
Gilead Sciences, Inc.3$68
Mirum Pharmaceuticals, Inc.1$18
AstraZeneca Pharmaceuticals LP1$14

Products named: REZDIFFRA, TERLIVAZ, XIFAXAN, CREON, IQIRVO, LINZESS, Bylvay, Livmarli.

Industry payments across NY — which companies pay providers there.